» Articles » PMID: 24840982

Unconventional Post-translational Modifications in Immunological Signaling

Overview
Journal Nat Immunol
Date 2014 May 21
PMID 24840982
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

The activity of a cell is governed by the signals it receives from the extracellular milieu, which are 'translated' into the appropriate biological output, such as activation, survival, proliferation, migration or differentiation. Signaling pathways are responsible for converting environmental cues into discrete intracellular events. The alteration of existing proteins by post-translational modification (PTM) is a key feature of signal-transduction pathways that allows the modulation of protein function. Research into PTMs has long been dominated by the investigation of protein phosphorylation; other PTMs, such as methylation of lysine and arginine residues, acetylation, and nitrosylation of thiol groups and tyrosine residues, have received comparatively little attention. This Review aims to present an overview of these PTMs, with an emphasis on their role in cells of the immune system.

Citing Articles

Benchmarking single-cell cross-omics imputation methods for surface protein expression.

Li C, Hong Y, Li B, Zhang X Genome Biol. 2025; 26(1):46.

PMID: 40038818 PMC: 11881419. DOI: 10.1186/s13059-025-03514-9.


Regulation of ovarian cancer by protein post-translational modifications.

Zhu Q, Zhou H, Xie F Front Oncol. 2024; 14:1437953.

PMID: 39678497 PMC: 11638062. DOI: 10.3389/fonc.2024.1437953.


Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives.

Luo Y, Lu J, Lei Z, Zhu H, Rao D, Wang T Biomark Res. 2024; 12(1):74.

PMID: 39080807 PMC: 11289998. DOI: 10.1186/s40364-024-00621-w.


Intricate effects of post-translational modifications in liver cancer: mechanisms to clinical applications.

Zhang Y, Xu W, Peng C, Ren S, Zhang C J Transl Med. 2024; 22(1):651.

PMID: 38997696 PMC: 11245821. DOI: 10.1186/s12967-024-05455-6.


Unconventional posttranslational modification in innate immunity.

Chen J, Qi D, Hu H, Wang X, Lin W Cell Mol Life Sci. 2024; 81(1):290.

PMID: 38970666 PMC: 11335215. DOI: 10.1007/s00018-024-05319-8.


References
1.
Hill J, Bell D, Brintnell W, Yue D, Wehrli B, Jevnikar A . Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med. 2008; 205(4):967-79. PMC: 2292232. DOI: 10.1084/jem.20072051. View

2.
Sambandam T, Belousova M, Accaviti-Loper M, Blanquicett C, Guercello V, Raijmakers R . Increased peptidylarginine deiminase type II in hypoxic astrocytes. Biochem Biophys Res Commun. 2004; 325(4):1324-9. DOI: 10.1016/j.bbrc.2004.10.173. View

3.
Kouzarides T . Chromatin modifications and their function. Cell. 2007; 128(4):693-705. DOI: 10.1016/j.cell.2007.02.005. View

4.
Li P, Li M, Lindberg M, Kennett M, Xiong N, Wang Y . PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010; 207(9):1853-62. PMC: 2931169. DOI: 10.1084/jem.20100239. View

5.
Moscarello M, PRITZKER L, Mastronardi F, Wood D . Peptidylarginine deiminase: a candidate factor in demyelinating disease. J Neurochem. 2002; 81(2):335-43. DOI: 10.1046/j.1471-4159.2002.00834.x. View